Terms: = Leukemia AND MAF, MGC71685, 4094, ENSG00000178573 AND Diagnosis
10 results:
1. miR-146a, miR-196a2, miR-499, and miR-149 linked with susceptibility to acute lymphoblastic leukemia: A case-control study in Tunisia.
Dhiflaoui A; Mahjoub S; Chayeb V; Achour B; Chouchen S; Abdennebi HB; Mahjoub T; Almawi WY
Gene; 2022 Aug; 834():146648. PubMed ID: 35690283
[TBL] [Abstract] [Full Text] [Related]
2. Ultra-Sensitive
Klimiankou M; Uenalan M; Kandabarau S; Nustede R; Steiert I; Mellor-Heineke S; Zeidler C; Skokowa J; Welte K
Front Immunol; 2019; 10():116. PubMed ID: 30891028
[TBL] [Abstract] [Full Text] [Related]
3. The histopathology of myeloma in the bone marrow.
Fujino M
J Clin Exp Hematop; 2018; 58(2):61-67. PubMed ID: 29998977
[TBL] [Abstract] [Full Text] [Related]
4. Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma.
Rajkumar SV; Gupta V; Fonseca R; Dispenzieri A; Gonsalves WI; Larson D; Ketterling RP; Lust JA; Kyle RA; Kumar SK
Leukemia; 2013 Aug; 27(8):1738-44. PubMed ID: 23515097
[TBL] [Abstract] [Full Text] [Related]
5. Characterization of c-maf transcription factor in normal and neoplastic hematolymphoid tissue and its relevance in plasma cell neoplasia.
Natkunam Y; Tedoldi S; Paterson JC; Zhao S; Rodriguez-Justo M; Beck AH; Siebert R; Mason DY; Marafioti T
Am J Clin Pathol; 2009 Sep; 132(3):361-71. PubMed ID: 19687312
[TBL] [Abstract] [Full Text] [Related]
6. In vitro activity of oxazaphosphorines in childhood acute leukemia: preliminary report.
Styczyński J; Wysocki M; Debski R; Balwierz W; Rokicka-Milewska R; Matysiak M; Balcerska A; Kowalczyk J; Wachowiak J; Sońta-Jakimczyk D; Chybicka A
Acta Biochim Pol; 2002; 49(1):221-5. PubMed ID: 12136944
[TBL] [Abstract] [Full Text] [Related]
7. High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies.
Avet-Loiseau H; Li JY; Facon T; Brigaudeau C; Morineau N; Maloisel F; Rapp MJ; Talmant P; Trimoreau F; Jaccard A; Harousseau JL; Bataille R
Cancer Res; 1998 Dec; 58(24):5640-5. PubMed ID: 9865713
[TBL] [Abstract] [Full Text] [Related]
8. Drug combination testing in acute lymphoblastic leukemia using the MTT assay.
Kaspers GJ; Veerman AJ; Pieters R; Van Zantwijk I; Hählen K; Van Wering ER
Leuk Res; 1995 Mar; 19(3):175-81. PubMed ID: 7700079
[TBL] [Abstract] [Full Text] [Related]
9. Allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission: the effect of FAB classification and GVHD prophylaxis.
Fagioli F; Bacigalupo A; Frassoni F; Van Lint MT; Occhini D; Gualandi F; Lamparelli T; Clavio M; Vitale V; Sogno G
Bone Marrow Transplant; 1994 Mar; 13(3):247-52. PubMed ID: 8199567
[TBL] [Abstract] [Full Text] [Related]
10. Cellular drug resistance profiles that might explain the prognostic value of immunophenotype and age in childhood acute lymphoblastic leukemia.
Pieters R; Kaspers GJ; van Wering ER; Huismans DR; Loonen AH; Hählen K; Veerman AJ
Leukemia; 1993 Mar; 7(3):392-7. PubMed ID: 8445945
[TBL] [Abstract] [Full Text] [Related]
